Poor air quality days significantly increase the risk of hospitalizations for respiratory issues in young survivors of cancer. Read more: https://medicalxpress.com/news/2019-04-air-pollution-poses-childhood-cancer.html

Rates of pediatric cancer have been rising since the 1980s; however, this increase varies by age group and cancer type. University of Minnesota researchers studied children under 5 years of age to understand cancer trends that occur in this age group around the world. Read more: https://twin-cities.umn.edu/news-events/research-brief-cancer-rates-young-children-are-increasing-worldwide

We are a sisterhood that we never imagined being a part of and never wanted to be in this group. We are a sisterhood united in caring for our children and helping them meet their highest potential. Read more: https://www.patheos.com/blogs/withoutacrystalball/2018/08/11222

The Cancer in Young People in Canada (CYP-C) Program maintains a national childhood cancer surveillance and research database that is available to researchers seeking to improve cancer diagnosis, treatment, and outcomes. Read more: https://www.canada.ca/en/public-health/services/publications/diseases-conditions/contribute-research-childhood-cancer-infographic.html

London, Ont. mother Kim Vander Schelde is fighting for the Canadian government to increase the funding towards childhood cancer research. This comes after watching her young child battle cancer, while being treated with adult medication. View interview: https://globalnews.ca/video/5173487/mother-seeks-additional-funding-for-childhood-cancer-research

Research led by Michael Lan, Ph.D., Professor of Pediatrics and Genetics at LSU Health New Orleans School of Medicine, found that a compound named 5'-iodotubercidin (5'-IT) suppresses the growth of neuroblastoma cells and identified a potential new therapeutic approach for the disease. Read more: https://medicalxpress.com/news/2019-04-rx-childhood-cancer.html

A recent study published in JAMA Oncology analyzed data generated from over 28,000 childhood cancer survivors and compared the lifetime cardiotoxicity risk in different chemotherapeutic drugs used for treatment. Read more: https://www.medicalnewsbulletin.com/chemotherapy-drugs-highest-cardiotoxicity-risk-pediatric-cancer/

A preclinical study that yielded new insights into a rare pediatric malignancy laid the foundation for a phase 2 trial that is evaluating a novel treatment approach in a specific type of kidney cancer. Read more: https://www.healio.com/hematology-oncology/genitourinary-cancer/news/online/%7Bcb9d14bb-4432-404c-8c94-cc7ca6b3c113%7D/trial-to-assess-novel-targeted-therapy-for-rare-form-of-kidney-cancer

Study results presented at the Oncology Nursing Society 44th Annual Congress described how parents use the Internet to build a support system. Read more: https://www.oncologynurseadvisor.com/uncategorized/how-parents-use-the-internet-to-cope-with-a-childs-cancer-diagnosis/

Researchers from Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania analyzed the largest cohort to date of pediatric patients with high-risk neuroblastoma treated with proton radiation therapy (PRT), finding both that proton therapy was effective at reducing tumors and demonstrated minimal toxicity to surrounding organs. Read more: https://www.eurekalert.org/pub_releases/2019-04/chop-pts040919.php